Anticonvulsive and neuroprotective actions of a potent agonist (DCG-IV) for Group II metabotropic glutamate receptors against intraventricular kainate in the rat
- 1 January 1997
- journal article
- Published by Elsevier in Neuroscience
- Vol. 77 (1) , 131-140
- https://doi.org/10.1016/s0306-4522(96)00442-3
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 47 references indexed in Scilit:
- Pharmacological tools for the investigation of metabotropic glutamate receptors (mGluRs): Phenylglycine derivatives and other selective antagonists—an updateNeuropharmacology, 1995
- Novel agonists for metabotropic glutamate receptors: trans- and cis-2-(2-carboxy-3-methoxymethylcyclopropyl)glycine (trans- and cis-MCG-I)Neuropharmacology, 1995
- Metabotropic glutamate receptors in brain function and pathologyTrends in Pharmacological Sciences, 1993
- In rats, the metabotropic glutamate receptor-triggered hippocampal neuronal damage is strain-dependentLife Sciences, 1993
- Molecular Diversity of Glutamate Receptors and Implications for Brain FunctionScience, 1992
- A potent metabotropic glutamate receptor agonist: electrophysiological actions of a conformationally restricted glutamate analogue in the rat spinal cord and Xenopus oocytesBrain Research, 1990
- Effects of status epilepticus on extracellular amino acids in the hippocampusBrain Research, 1985
- Kainic acid stimulates excitatory amino acid neurotransmitter release at presynaptic receptorsNature, 1982
- Kainic acid induced limbic seizures: metabolic, behavioral, electroencephalographic and neuropathological correlatesBrain Research, 1981
- Intraventricular kainic acid preferentially destroys hippocampal pyramidal cellsNature, 1978